Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Shanghai Pharmaceutical
Asia
China's NRDL, Biocon-Viatris and more—Fierce Pharma Asia
China's new NRDL excludes pricey I-O meds. Biocon and Viatris are reportedly considering a biosimilar merger. A Chinese biotech got $200 million.
Angus Liu
Dec 10, 2021 8:45am
Syntegon and Shanghai Pharma to build lab for novel drug process
Dec 9, 2021 10:40am
China's PD-1s, Fujifilm, Sinopharm and more—Fierce Pharma Asia
Jan 8, 2021 9:08am
Shanghai Pharma maps $1.18B construction project in hometown hub
Jan 5, 2021 7:43am
FiercePharmaAsia—Astellas, Brii's $260M, Sun and more
May 25, 2018 9:30am
FiercePharmaAsia—Takeda, Shanghai Pharma, WuXi NextCODE
Jan 26, 2018 9:37am
